HLA-E and neoplasm: In addition, a recent report identified widespread HLA-E expression in tumour samples, with levels correlating to those of NKG2A. This is of importance as one mechanism of tumour resistance to immune cells is mediated by the expression of peptide-loaded HLA class I molecule (HLA-E) in tumour cells.